RhumbLine Advisers’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-43,273
| Closed | -$20.6K | – | 4198 |
|
|
2025
Q1 | $20.6K | Buy |
43,273
+182
| +0.4% | +$87 | ﹤0.01% | 3733 |
|
|
2024
Q4 | $43.5K | Sell |
43,091
-6,771
| -14% | -$6.84K | ﹤0.01% | 3677 |
|
|
2024
Q3 | $85.3K | Sell |
49,862
-2,604
| -5% | -$4.45K | ﹤0.01% | 3548 |
|
|
2024
Q2 | $134K | Buy |
52,466
+18,828
| +56% | +$48K | ﹤0.01% | 3416 |
|
|
2024
Q1 | $141K | Buy |
33,638
+692
| +2% | +$2.89K | ﹤0.01% | 3331 |
|
|
2023
Q4 | $109K | Sell |
32,946
-1,256
| -4% | -$4.17K | ﹤0.01% | 3422 |
|
|
2023
Q3 | $68.4K | Buy |
34,202
+750
| +2% | +$1.5K | ﹤0.01% | 3576 |
|
|
2023
Q2 | $106K | Buy |
33,452
+2,350
| +8% | +$7.43K | ﹤0.01% | 3508 |
|
|
2023
Q1 | $108K | Buy |
31,102
+363
| +1% | +$1.26K | ﹤0.01% | 2846 |
|
|
2022
Q4 | $158K | Buy |
30,739
+222
| +0.7% | +$1.14K | ﹤0.01% | 2840 |
|
|
2022
Q3 | $302K | Buy |
30,517
+1,939
| +7% | +$19.2K | ﹤0.01% | 2725 |
|
|
2022
Q2 | $240K | Buy |
28,578
+13,617
| +91% | +$114K | ﹤0.01% | 2857 |
|
|
2022
Q1 | $188K | Buy |
+14,961
| New | +$188K | ﹤0.01% | 2772 |
|
|
2021
Q4 | – | Sell |
-8,697
| Closed | -$219K | – | 3009 |
|
|
2021
Q3 | $219K | Buy |
+8,697
| New | +$219K | ﹤0.01% | 2877 |
|